Is Cresco Labs Inc (CRLBF) a Good Choice in Drug Manufacturers

Cresco Labs Inc (CRLBF) is around the middle of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. CRLBF received an overall rating of 44, which means that it scores higher than 44 percent of all stocks. Cresco Labs Inc also achieved a score of 59 in the Drug Manufacturers - Specialty & Generic industry, putting it above 59 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 91 out of the 148 industries.

CRLBF has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on CRLBF!

See Full CRLBF Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 44 would rank higher than 44 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cresco Labs Inc Stock Today?

Cresco Labs Inc (CRLBF) stock is trading at $2.23 as of 11:14 AM on Thursday, Mar 28, of $0.00, or 0% from the previous closing price of $2.23. Volume today is below average. So far 317,645 shares have traded compared to average volume of 736,539 shares. The stock has traded between $2.16 and $2.25 so far today. Click Here to get the full Stock Report for Cresco Labs Inc stock.